MedTrace Logo

Evaluation of a New Silicone Hydrogel Contact Lens

NCT01309880 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2015-02-23

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.

Conditions

  • Myopia

Interventions

DEVICE

Test lens

Investigational silicone hydrogel contact lens worn on a daily wear basis

DEVICE

Air Optix Aqua

Air Optix Aqua contact lens worn on a daily wear basis

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Beverly Barna · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2010-12-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01309880 on ClinicalTrials.gov